🔎 Trials Near Me

Dachaigh › Cancer Ovarian › Minnesota › Minneapolis

Sgrùdaidhean clionaigeach Cancer Ovarian ann an Minneapolis, MN

Tha 24 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Minneapolis (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

The Vanguard Study: Testing a New Way to Screen for Cancer

A’ fastadhFàilte do shaor-thoilich fhallain
  • Minneapolis VA Medical Center, Minneapolis
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06995898

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

A’ fastadhÌre 3
  • Masonic Cancer Center, University of Minnesota, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 5 Dàmh 2026 · NCT06915025

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

A’ fastadhÌre 2
  • Abbott-Northwestern Hospital, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

A’ fastadhÌre 2
  • Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

A’ fastadhÌre 2
  • University Of Minnesota /ID# 277850, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT07024784

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

A’ fastadhÌre 2
  • University of Minnesota - Minneapolis /ID# 275718, Minneapolis
  • Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · 5 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT06890338

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

A’ fastadhÌre 2
  • Minnesota Oncology-Minneapolis, Minneapolis
Aoisean 18 gu 99 · Banairean · Air ùrachadh 15 Sult 2026 · NCT07023627

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • University of Minnesota Masonic Cancer Center, Minneapolis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07216105

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

A’ fastadhÌre 1
  • University of Minnesota, Minneapolis
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

A’ fastadhÌre 1/2
  • University of Minnesota/Masonic Cancer Center, Minneapolis
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

A’ fastadhÌre 1
  • Normunity Investigational Site, Minneapolis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A’ fastadh
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Health Partners Inc, Minneapolis
  • agus 2 a bharrachd
Aoisean 35 gu 50 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

A’ fastadhÌre 3
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Health Partners Inc, Minneapolis
  • agus 2 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

A’ fastadhÌre 1/2
  • M Health Fairview University of Minnesota Medical Center, Minneapolis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06330064

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

A’ fastadhÌre 2
  • 518, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 16 Iuch 2026 · NCT06906341

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A’ fastadhÌre 2
  • University of Minnesota - Masonic Cancer Center, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 14 Iuch 2026 · NCT04606914

UNTOLD Ovarian Cancer Unmet Needs Survey

A’ fastadhSgrùdadh amharc
  • Masonic Cancer Center, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 8 Iuch 2026 · NCT07070726

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A’ fastadhÌre 1
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04389632

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

A’ fastadhÌre 3
  • Minnesota Oncology Hematology PA, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Iuch 2026 · NCT06819007

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

A’ fastadhFàilte do shaor-thoilich fhallain
  • University of Minnesota, Minneapolis
Aoisean 50 gu 74 · Banairean · Air ùrachadh 6 Cèit 2026 · NCT00539162

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

A’ fastadhÌre 1
  • University of Minnesota, Minneapolis
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Allina Health Cancer Institute, Minneapolis
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

A’ fastadhÌre 2
  • SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
  • University of Minnesota, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 23 Dùbh 2025 · NCT06690775

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

A’ fastadhÌre 1
  • University of Minnesota, Minneapolis
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 18 Dùbh 2025 · NCT07030907

Sgrùdaidhean Cancer Ovarian ann am bailtean eile

Sgrùdaidhean eile ann an Minneapolis

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.